Quest Diagnostics Incorporated (NYSE:DGX) Stock is Soaring, Here is Why

Quest Diagnostics Incorporated (NYSE:DGX) Stock is Soaring, Here is Why


The Quest Diagnostics Incorporated (DGX) shares are trading at higher $108.30 and the avg recommendation for the stock is Moderate Buy. The current analyst price target stands at $126.54.

To add more color to this target, the company’s high over the last year is $125.00 and the low is $73.02. Over the last 52 weeks, DGX is down -13.36% while the S&P 500 is up 1.07%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, DGX reported a profit of $552.0 million. Quest Diagnostics Incorporated also saw revenues increase to $1.82 billion. In addition, DGX has free cash flow of $164.0 million as of 03-2020 The company’s EBITDA came in at $260.0 million which compares well with its peers.

DGX booked profit margins of 10.30%, its Return on Equity (ROE) is 14.10%, and its Return on Assets is 6.50%. All told, it is clear that, DGX needs to be on your watchlist.

Find out when DGX reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. DGX has a short ratio of 2.09 and outstanding shares of 134.00M.

Company Outlook

DGX has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 1.33 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 5.66. Quest Diagnostics Incorporated DGX also noted assets of $12.05 billion at the end of the last quarter. Investors should also keep an eye on sector updates as DGX has historically followed its peers on positive news.

All told, Quest Diagnostics Incorporated DGX has strung together solid data and demonstrated underlying fundamentals. At its current valuation, DGX represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Quest Diagnostics Incorporated DGX is now commanding a market cap of 14.86B and a float of 133.06M. DGX is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of DGX stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in DGX, either long or short, and we have not been compensated for this article.